ImpediMed Limited

ImpediMed Limited is a global medical technology company focused on the development and commercialization of innovative bioimpedance spectroscopy (BIS) devices. These devices are used for the non-invasive assessment of fluid status and tissue composition. The company's core technology aids clinicians in the early detection and management of diseases and conditions such as lymphedema, heart failure, and kidney disease. ImpediMed's products offer a convenient and objective method for monitoring patient health, potentially leading to improved outcomes and reduced healthcare costs. By providing valuable insights into fluid shifts and body composition, ImpediMed aims to empower healthcare professionals to make more informed decisions and personalize treatment strategies. The company operates within the medical device sector, contributing to advancements in diagnostic and monitoring capabilities for a range of medical specialties.